David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$397M |
| 2 |
YHOO
Yahoo Inc
YHOO
|
+$342M |
| 3 |
Bank of America
BAC
|
+$322M |
| 4 |
Citigroup
C
|
+$260M |
| 5 |
Booking.com
BKNG
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$637M |
| 2 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$397M |
| 3 |
Gilead Sciences
GILD
|
+$358M |
| 4 |
Phillips 66
PSX
|
+$330M |
| 5 |
Apple
AAPL
|
+$320M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.78% |
| 2 | Technology | 11.11% |
| 3 | Financials | 10% |
| 4 | Consumer Discretionary | 8.83% |
| 5 | Communication Services | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2176
Curis
CRIS
$3.71M
| $1.26M | ﹤0.01% |
392
-22
| -5% | -$74K |
|
2177
CALL
Polaris
PII
$3.62B
| $1.26M | ﹤0.01% |
12,800
+2,500
| +24% | +$217K |
|
|
GSIG
2178
DELISTED
GSI GROUP INC COM STK (CDA)
GSIG
| $1.26M | ﹤0.01% |
88,889
+5,311
| +6% | +$68.1K |
|
2179
Artivion
AORT
$1.29B
| $1.26M | ﹤0.01% |
117,018
+11,964
| +11% | +$122K |
|
2180
PUT
Alnylam Pharmaceuticals
ALNY
$32.2B
| $1.25M | ﹤0.01% |
+20,000
| New | +$1.33M |
|
2181
CALL
GSK
GSK
$104B
| $1.25M | ﹤0.01% |
24,720
| – | – |
|
2182
Mizuho Financial
MFG
$127B
| $1.25M | ﹤0.01% |
426,159
+9,074
| +2% | +$29.5K |
|
|
DL
2183
DELISTED
China Distance Education Holdings Limited
DL
| $1.25M | ﹤0.01% |
85,010
+6,051
| +8% | +$76.9K |
|
|
CBPO
2184
CALL
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $1.25M | ﹤0.01% |
10,900
-4,500
| -29% | -$528K |
|
|
PRXL
2185
DELISTED
Parexel International Corp
PRXL
| $1.25M | ﹤0.01% |
+19,839
| New | +$1.22M |
|
2186
CALL
United Rentals
URI
$65.9B
| $1.24M | ﹤0.01% |
20,000
-156,500
| -89% | -$8.7M |
|
|
BITA
2187
CALL
DELISTED
Bitauto Holdings Limited
BITA
| $1.24M | ﹤0.01% |
50,000
+10,000
| +25% | +$220K |
|
2188
Comstock Resources
CRK
$4.36B
| $1.24M | ﹤0.01% |
322,670
+122,703
| +61% | +$686K |
|
|
IXYS
2189
DELISTED
IXYS Corp
IXYS
| $1.24M | ﹤0.01% |
110,067
+26,400
| +32% | +$299K |
|
2190
Diodes
DIOD
$4.25B
| $1.23M | ﹤0.01% |
61,395
+18,570
| +43% | +$356K |
|
|
AMRI
2191
DELISTED
Albany Molecular Research Inc
AMRI
| $1.23M | ﹤0.01% |
80,618
+33,854
| +72% | +$531K |
|
2192
PUT
Autohome
ATHM
$2.52B
| $1.23M | ﹤0.01% |
+44,000
| New | +$1.16M |
|
2193
CALL
Ciena
CIEN
$55.8B
| $1.23M | ﹤0.01% |
64,500
-8,800
| -12% | -$163K |
|
|
POLY
2194
DELISTED
Plantronics, Inc.
POLY
| $1.23M | ﹤0.01% |
31,324
-15,991
| -34% | -$626K |
|
|
WGL
2195
DELISTED
Wgl Holdings
WGL
| $1.23M | ﹤0.01% |
+16,957
| New | +$1.13M |
|
2196
Avis
CAR
$5.07B
| $1.23M | ﹤0.01% |
44,798
-86
| -0.2% | -$2.35K |
|
2197
Northwest Bancshares
NWBI
$2.25B
| $1.23M | ﹤0.01% |
90,710
-10,994
| -11% | -$140K |
|
|
AVDL
2198
DELISTED
Avadel Pharmaceuticals
AVDL
| $1.22M | ﹤0.01% |
110,830
+5,934
| +6% | +$58.9K |
|
|
RAD
2199
PUT
DELISTED
Rite Aid Corporation
RAD
| $1.22M | ﹤0.01% |
7,500
-9,230
| -55% | -$1.46M |
|
|
UBNK
2200
DELISTED
United Financial Bancorp, Inc.
UBNK
| $1.22M | ﹤0.01% |
96,994
+43,097
| +80% | +$509K |
|
Similar funds
David Shaw's Q1 2016 Portfolio in Review
As of Q1 2016, David Shaw held 4,137 positions worth $55.7B, down 17% from $67.2B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
David Shaw withdrew a net $9.72B in Q1 2016, closing 773 positions and reducing 1,495 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $637M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
Against the trend, David Shaw opened a new position in EQT Corp worth $47.6M.
- David Shaw's largest Q1 2016 buy was EQT Corp: 1,300,361 shares worth $47.6M.
- David Shaw added most to Allergan plc in Q1 2016, an estimated $397M increase.
- David Shaw's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $358M.
- David Shaw fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $637M.
- David Shaw's ten largest holdings make up 9.5% of its $55.7B portfolio in Q1 2016.
- David Shaw opened 382 new positions and closed 773 in Q1 2016.
- David Shaw's portfolio value fell 17% quarter-over-quarter to $55.7B.
Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.